🔗 Share this article

An underground economy for unlicensed weight-loss drugs is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Experimental Treatment Acquiring Traction Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Followers are encouraged to contact these accounts privately for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where communities with numerous of members share “before and after” photos, administration instructions and claims of next-day British shipping. Vendors market the drug there before directing buyers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Concerns

However, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals administering products of uncertain source.

Several experts said the demand for retatrutide could be connected to the rising price of licensed slimming products such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the British medical regulations.

Some influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still violate medicines, marketing, and consumer laws, risking penalties, prosecution or imprisonment.

Service Response and Content Removal

Based on TikTok, the platform has removed violative material and banned related hashtags and search suggestions. The organization stated it was dedicated to maintaining the platform secure and investing in strengthening enforcement strategies.

Digital Marketplace Activities

Research also found communities with up to 9,000 members selling retatrutide using the platform's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays groups with thousands of members, populated with photos of slimming results, glowing reviews and step-by-step instructions for mixing or injecting at home.

After moments of joining one group, a seller shared contact information, where the majority of purchases take place. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one inquired about body mass, health issues or previous experience.

Item Details and Pricing

Within these communities, messages show dark colored parcels with Royal Mail stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with sterile water, or ready-to-use injectors typically sold at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service stated it regularly monitored dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting materials they can’t verify. Even if the research behind this drug is valid, these digital versions may not include what they claim,” said Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.

Her team has previously encountered individuals harmed by self-injection from unverified sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose patients to possibly serious health risks”.